Roth Capital Starts Rigel Pharmaceuticals (RIGL) at Buy
Tweet Send to a FriendGet Alerts RIGL Hot Sheet
Price: $4.58 -3.38%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade RIGL Now!
Roth Capital initiates coverage on Rigel Pharmaceuticals (NASDAQ: RIGL) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Rigel Pharmaceuticals click here. For more ratings news on Rigel Pharmaceuticals click here.
Shares of Rigel Pharmaceuticals closed at $9.89 yesterday, with a 52 week range of $6.60-$11.44.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Rigel Pharmaceuticals click here. For more ratings news on Rigel Pharmaceuticals click here.
Shares of Rigel Pharmaceuticals closed at $9.89 yesterday, with a 52 week range of $6.60-$11.44.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
- BMO Capital Starts Student Transportation (STB) at Market Perform
- Stifel Nicolaus Starts Harris Corp. (HRS) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
